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The DNA binding activities of some basic region and putative helix-loop-helix (bHLH)-containing transcrip-
tional factors can be inhibited by the Id protein. Because Id contains the HLH motif for dimerization but not
the basic amino acid region for DNA binding, heterodimers of Id with bHLH transcriptional factors may not
bind to DNA. We have isolated and characterized the gene and cDNA clones for a new Id protein, designated
Id2. The Id2 protein contains a helix-loop-helix motif similar to that of the previously described Id protein
(referred to here as Idl), but the two proteins are different elsewhere. Idl and Id2 are encoded by two unlinked
genes, as shown by chromosome mapping. The two Id proteins have similar inhibitory activities. They
selectively bind to and inhibit the function of one set of bHLH proteins, typified by E2A.E47 and E2B.m3, but
not that of the other set, including TFE3, USF, and AP4. The Id proteins also homodimerize poorly. Expression
of both Id genes is down-regulated during differentiation in a variety of cell types.
A large family of proteins, mostly transcriptional activa-
tors, share a common DNA binding motif, thought to be
composed of a basic amino acid region and a helix-loop-helix
region (bHLH) (29). The bHLH proteins form homo- and
heterodimers through the helix-loop-helix regions and bind
to specific DNA sequences with the basic region (14, 45).
These proteins have been shown to play important and
specific roles in the differentiation of specific cell types. For
example, the bHLH proteins MyoD, myogenin, MRF4, and
Myf5 (8, 15, 16, 35, 46), control aspects of gene expression in
differentiating muscle cells, while E12 and E47, two differ-
entially spliced products of the E2A gene (30, 42), have
multiple transcriptional activating functions in differentiating
B lymphocytes, muscle cells, pancreatic ,-cells, nerve cells,
and perhaps others (29). It is thus important to understand
specific regulation of the functions of these proteins. Some
regulation is achieved by cell-type- and stage-specific
expression of the bHLH proteins, as in the muscle-specific
expression of MyoD (15). In other cases the function of
expressed bHLH proteins is controlled by their intrinsic
inability to bind to DNA as in E12 homodimers (42). Addi-
tional mechanisms must exist to regulate the activities of
certain constitutively expressed and yet active DNA binding
proteins such as the E47 homodimer.
The discovery of the Id protein provided a new perspec-
tive for considering the regulation of bHLH proteins (6). Id
protein contains a helix-loop-helix region similar to that of
the bHLH proteins and can form heterodimers with some of
them. But these heterodimers cannot bind to DNA, because
the Id protein lacks the apparent basic region responsible for
DNA binding; Id therefore negatively regulates the DNA
binding capacity of bHLH proteins. Benezra et al. (6) have
shown that the Id protein not only inhibits the DNA binding
activities of E12, E47, and MyoD homo- and heterodimers in
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vitro, but also inhibits the transcriptional activation by
MyoD when Id is expressed in cells with the MyoD gene and
a reporter gene, demonstrating that Id is an effective nega-
tive regulator acting directly on the bHLH proteins. Id also
has a Drosophila homolog, extramachrochaetae (emc),
whose mutant phenotype suggests that emc inhibits the
functions of the daughterless and achaete-scute proteins (17,
19), two bHLH proteins involved in sex determination and
neurogenesis in Drosophila melanogaster (2, 12, 13, 44).
To more fully understand the role of Id in the regulation of
bHLH proteins in various cellular processes, we have ad-
dressed the following questions: Is there more than one Id
protein? Many bHLH proteins exist; are all inhibited by the
Id proteins? Finally, are the genes for the Id proteins
regulated? For example, in what cells and at what develop-
mental stages is an Id expressed? To begin to define these
issues, we report here a genomic clone and its cDNA clones
which encode a new Id protein, designated Id2. Id2 is very
similar in the helix-loop-helix motif to the first Id protein,
referred to as Idl, but the two Id proteins are very different
elsewhere. We then investigated the inhibitory specificities
of Idl and Id2 on bHLH proteins and found that while both
Idl and Id2 inhibit DNA binding by certain bHLH proteins
like E2A.E47 and another close relative, E2B.m3, neither of
them inhibits the binding by other bHLH proteins such as
c-Myc, TFE3, USF, and AP4. We also directly examined
heterodimer formation of the two Id proteins with various
bHLH proteins as well as homodimer formation between
them. The expression of the two Id genes is down-regulated
in parallel during differentiation of many different cell types,
which is consistent with a role for both as negative regulators
that inhibit the function of bHLH proteins until cells have
initiated a program of terminal differentiation.
MATERIALS AND METHODS
Cell lines, RNA isolation, and analysis. The mouse B
lymphoid cell lines HAFTL (1), PD31, and WEHI-231 were
maintained in RPMI medium containing 10% fetal calf se-
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GENOMIC gaattcgcctggtatgatggacgggagccttccaccaatggcaattcagggAtgcccgattgagcgccagggcgagtqcacataaaagacgccccgcccggctcgcgcttcattctgADNA * W T G A L P P M A I Q G C P I E R P G R V H I 1K D A P P G S R F I L N
I-exon 1-
cDNA ACCGAGCCTGGTGCCGCGCAGTCAGCTCAGCCCCCTGTGGCGGCTCCCTCCCGGTCTCTCCTCCTACGAGCAGCATGAAAGCCTTCAGGTCCGGTGAGTCCGTTAGGAAAAACAGCCTGT
R A N C R A V S S A P C G G S L P V S P P T S S M K A F R S G E S V R K N S L S
CGGACCACAGCTTGGGCATCTCCCGGAGCAAAACCCCGGTGGACGACCCGATGAGTCTGCTCTACAACATGAACGACTGCTACTCCAAGCTCAAGGAACTGGTGCCCAGCATCCCCCAGA
D H S L G I S R S K T P V D D P N S L L Y N MN D C Y S K L K E L V P S I P Q N
ACAAGAAGGTGACCAAGATGGAAATCCTGCAGCACGTCATCGATTACATCTTGGACCTGCAGATCGCCCTGGACTCGCATCCCACTATCGTCAGCCTGCATCACCAGAGACCTGGACAGA
K K V T K N E I L Q H V I D Y I L D L Q I A L D S H P T I V S L H H Q R P G Q N
ACCAGGCGTCCAGGACGCGCCTGACCACCCTGAACACGGACATCAGCATCCTGTCCTTGCAGGCATCTGAATTCCCTTCTGAGCTTATGTCGAATGATAGCAAAGTACTCTGTGGCTAAA
Q A S R T R L T T L N T D I S I L S L Q A S E F P S E L M S N D S K V L C G *
exon 1+exon 2
TAAATGGCATTTGGGGACTTTTTCTTTTCTTTTTACTTTCTCTTTTTCTTTTGCACAAGAAGAAGTCTACAAGATCTTTTAAGACTTTTGTTATCAGCCATTTCACCAGGAGAACACGTT
exon 2Fexon 3
GAATGGACCTTTTTAAAAGAAGCAGCGGAAGAAAACTAAGGTGATGTGTCTTGCCCAGGTGTCGTTCTCCGGCCTGGACTGTGATACCGTTATTTATGAGAGACTTTCAGTGCCCTTTCT
ACAGTTGGAAGGTTTTCTTTATATACTATTCCCACCATGGGGAGCGAAAAGGTTAAAAAAAAAATCACAAGGAATTGCCCAATGTAAGCAGACTTTGCCTTTTCACAAAGGTGG
AGCGTGAATTCCAGAAGGACCCAGTATTCGGTTACTTAAATGAAGTCTTCGGTCAt;AATGGCCTTTTTGACACGAGCCTACTGAATGCTGTGTATATATTTATATATAAATATATATAT
ATTGAGTGAACCTTGTGGACTCTTTAATTAGAGTTTTCTTGTATAGTGGCAGAAATAACCTATTTCTGCATTAAAATGTAATGAiCGTACTTATGCTAAACTTTTTATAAGTTTAGTTG
TAAACTTAACCCTTTTATACAAAATAAATCAAGTGTGTTTATTGAATGTTGATTGCTTGCTTTATTTCAGACAACCAGTGCTTTGATTTTTTTTATGCTATGTTATAACTGAACC:CAAAT
AAATACCAGtTCAAATTTATGTAGACTGTATTAGATTATATA&AMATGTGTCTGACATCAAAAAAAAAAA
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FIG. 1. Structure of the Id-2 gene and its cDNA. (A) Restriction map of Id-2 locus. The thin line represents the locus, and exons are shown
in hatched boxes and numbered 1, 2, and 3. H, HindlIl; R, EcoRI; B, BamHI. (B) DNA sequence of a chimeric Id2 clone. The sequence of
an EcoRI genomic fragment overlaps with the sequence of a partial cDNA between nucleotide 120 and 542. The first 119 bp of the sequence
was from the genomic fragment shown in lowercase characters and speculated to be part of the exon 1 (underlined with a dashed line). Each
exon is bracketed with horizontal and vertical lines and labeled at both ends of the exon. The polyadenylation signal is underlined. The two
potential initiation methionine residues are shown in bold, and the first ATG is marked with an asterisk.
rum. LyD9 cells (33) were grown in Iscove modified
Dulbecco's medium supplemented with 5% fetal calf serum
and 10% WEHI-3 cell supernatant as a source of interleu-
kin-3, 2 ,uM glutamine, and 50 ,uM ,3-mercaptoethanol.
Murine erythroleukemia (MEL) cells (cell line 745-PC3-A21)
(34) were grown to the density of 2 x 105 cells per ml in
Dulbecco modified Eagle medium with 10% fetal calf serum
and induced to differentiate for 48 h at 37°C with 1.5%
dimethyl sulfoxide. The undifferentiated MEL cell sample
was grown the same way without dimethyl sulfoxide treat-
ment. The mouse F9 embryonal carcinoma cell line was
grown in Dulbecco modified Eagle medium with 10% calf
serum and treated for 120 h with 1 ,uM retinoic acid, 250 ,uM
cyclic AMP, and 250 puM theophylline to differentiate the
cells into parietal endoderm-like cells (41). The F9 stem cells
were treated with the vehicles of the drugs, which were
ethanol and water.
RNA was isolated from these cells by the guanidinium-
CsCl2 method as previously described (4) and analyzed by
Northern (RNA) blot analysis (4). About 5 ,ug of each RNA
was analyzed by electrophoresis through a 1% agarose gel
containing ethidium bromide, and the gel was photographed
with type 55 Polaroid film, which also gave a negative film.
The intensities of the rRNA bands were quantitated by
scanning the negative film with an ultrascan laser densitom-
eter 2202 (LKB; Pharmacia), and the values were used to
normalize the concentrations of all RNA samples against
that of the LyD9 RNA. Fifteen micrograms of each RNA
was then analyzed by electrophoresis through a 1% formal-
dehyde gel as previously described (4). The filter was hy-
bridized with either a 900-bp fragment containing Idl cDNA
or a 900-bp fragment of Id-2 genomic DNA containing 540 bp
of exon 1 (Fig. 1B) at high stringency (50% formamide-5x
SSC [1 x SSC is 0.15 M NaCl plus 0.015 M sodium citrate] at
420C).
Cloning and analysis of Id-2 genomic and cDNA clones. A
mouse genomic DNA library was constructed by cloning
Sau3AI partial digestion fragments into the X phage EMBL4
vector. The library was screened with the 900-bp Idl cDNA
probe at high stringency (50% formamide-5 x SSC at 420C).
A mouse thymus cDNA library cloned in the pcDNA II
plasmid vector (Invitrogen) was screened with a 900-bp
EcoRI genomic fragment of the Id-2 gene at high stringency.
DNA sequencing was performed by using the dideoxynucle-
otide chain termination method (37) with single-stranded
plasmids as templates (4) prepared from the pcDNA II
plasmids for cDNA clones and from the Bluescript plasmids
(Stratagene) for genomic DNA subclones. The restriction
map of the Id-2 gene X clone was obtained by Southern
analysis (4) with the Idl cDNA and the Id2 cDNA as probes.
B.
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A chimeric Id2 clone was constructed by replacing a 400-bp
EcoRI-Clal genomic DNA fragment containing exon 1 with
a 280-bp XhoI-ClaI cDNA fragment in the cId2-k cDNA
clone (Fig. 1B).
Chromosome mapping by interspecffic backcross. Interspe-
cific backcross progeny were generated by mating (C57BL/
6J x Mus spretus)Fj females and C57BL/6J males as previ-
ously described (11). A total of 205 N2 progeny were
obtained; a random subset of these N2 mice were used to
map the Id-2 locus. DNA isolation and Southern blot anal-
ysis were performed essentially as previously described (25).
All blots were prepared with Zetabind nylon membrane
(AMF-Cuno). The Id2 cDNA probe (nucleotides 342 to 1394
[Fig. 1B]) was labeled with [ct-32P]dCTP by using a nick
translation kit (Boehringer Mannheim). Washing was done
to a final stringency of 0.2x SSC-0.1% sodium dodecyl
sulfate (SDS) at 65°C. Fragments of 7.6 and 5.8 kb were
detected in XbaI-digested C57BL/6J DNA; fragments of 9.0
and 5.8 kb were detected in XbaI-digested M. spretus DNA.
A description of the probes and restriction fragment length
polymorphisms for the proopiomelanocortin-1 (Pomc-1),
chromosome 12 DNA segment Nyu2 (D12Nyu2), the N-myc
proto-oncogene (Nmyc), and laminin Bl-1 (Lambl-]) have
been reported previously (26, 32, 39). Recombination dis-
tances were calculated as previously described (20) by using
the computer program SPRETUS MADNESS developed by
D. Dave (Data Management Services, Inc., Frederick, Md.)
and A. M. Buchberg (ABL-Basic Research Program, Na-
tional Cancer Institute, Frederick, Md.). Gene order was
determined by minimizing the number of recombination
events required to explain the allele distribution patterns.
In vitro transcription and translation. To generate Idl and
Id2 proteins by in vitro translation, the DNA templates were
first prepared by polymerase chain reaction (PCR) (36). The
primers used for PCR were as follows:
Idl sense, GCAATrAACCCTCACTAAAGGGTACCGTACAACCTITCTCCAACTTC
Idl antisense, GGCTGGAGTCCATCTGGTCCCTCAGTGC
1d2 sense, GCAATTAACCCTCACTAAAGGGTACCATGGCAATTCAGGGATGC
1d2 antisense, GGCGGATCCTrAlTIAGCCACAGAGTAC
The sense primers of Idl and Id2 both contain sequences for
the T3 promoter (nucleotide 1 to 19) and transcription
initiation site (nucleotide 20). The additional sequence in the
Idl primer includes Idl 5' untranslated sequence (nucleo-
tides 27 to 47 of the primer), and that in the Id2 primer
contains the consensus sequence for translation initiation
(nucleotides 24 to 29 of the primer) and the Id2 coding
sequence beginning at the second codon (Fig. 1B). The
antisense primers of Idl and Id2 hybridize to the sequences
near the translation termination codon. Each pair of primers
was used in a PCR with an Idl cDNA clone (6) or the
chimeric Id2 clone as a template (Fig. 1B). The PCR prod-
ucts were extracted with phenol-chloroform and precipitated
with ethanol. An aliquot of the products (1/10 to 1/5) was
used as a template for the in vitro transcription reaction by
using T3 polymerase as described by the vendor (Boehringer
Mannheim). The RNAs were extracted with phenol-chloro-
form and precipitated with ethanol. Ten percent of each
product was then used for the in vitro translation reaction
with rabbit reticulocyte lysates and [35S]methionine as de-
scribed by the vendor (Promega). One microliter of each
50-pdl translation reaction mix was analyzed by electropho-
resis through a SDS-polyacrylamide gel and autoradio-
graphed to estimate the molar amounts of protein produced
by comparing the intensities of the protein bands corrected
by the number of methionines present in each protein.
To obtain the DNA templates for TFE3, USF, and AP4, a
pair of primers was designed for each protein in the same
way as those for Id2 protein, i.e., the sense primer contains
the T3 promoter, transcription start site, translation signal,
and specific coding sequence at the indicated position, and
the antisense primer has the sequence at the indicated
positions (see Fig. 5A). These primers were then used in
PCR with a pool of HeLa cell cDNAs as a template. The
PCR products were purified from a low-melting-point agar-
ose gel and used as templates for an additional round of
PCR. The products were then used for the in vitro transcrip-
tion and translation reactions as described above.
To produce full-length MyoD and truncated forms of E47,
m3 and c-myc, linearized plasmid DNAs, pMyoD (pV2Cllb)
(15), pE47S (30), pM3, and pMyc were used as templates to
produce RNAs by in vitro transcription reactions. The
plasmids, pM3 and pMyc, were constructed by cloning PCR
products, containing the indicated m3 and c-myc sequences
(see Fig. 4A and 5A) into the NcoI and HindIlI sites of a
Bluescript-based translation vector (Stratagene; R. Andino,
Whitehead Institute for Biomedical Research). The PCR
products were obtained by using primers which contain the
sense and antisense coding sequences with an Ncol site and
an HindIII site at the ends. The RNA products were trans-
lated as described above.
DNA binding inhibition assays. In vitro-translated Id pro-
teins were first mixed with various DNA binding bHLH
proteins at the indicated molar ratio in a final volume of 10 RI
equalized with a mock-translated lysate and incubated at
37°C for 20 min. Ten microliters of DNA binding mixes
containing 20 mM Tris (pH 7.5), 100 mM NaCl, 2 mM
dithiothreitol, 2 mM EDTA, 10% glycerol, 1 ,ug of poly(dI-
dC), and 32P-labeled probes (104 cpm) containing the appro-
priate binding sites was then added to the proteins, and the
mixtures were incubated for 15 min at room temperature.
The reactions were analyzed by electrophoresis through a
4% polyacrylamide gel in 0.5x TBE buffer (0.045 mM Tris,
0.045 mM boric acid, 0.05 mM EDTA).
Interaction of Ids with bHLH proteins. To generate Id
fusion proteins with glutathione S-transferase (GST), a PCR-
amplified fragment containing full-length Idl or Id2 with
artificial BamHI sites on both ends was cloned into the
BamHI site in the expression vecter pGex-2T (40). The GST
fusion proteins with C-terminal portions of E2A.E12 (amino
acid 493 to 654) and E2A.E47 (amino acid 525 to 609) (27)
were constructed by cloning, into the SmaI and EcoRI sites
of pGex-2T, a blunt NotI-EcoRI fragment of pE12 (30) and a
blunt NcoI-EcoRI fragment of pE47S (30). These plasmids
were transformed into NB42, an Escherichia coli strain with
the Ion mutation genotype, for protein production.
Log-phase E. coli cultures were induced with 0.4 mM
isopropyl-,B-D-thiogalactopyranoside (IPTG) for 1 h, and
crude extracts were prepared as previously described (42).
To purify the proteins, 1 ml of 50o slurry of glutathione-
agarose (Sigma) was added to each 15-ml extract and mixed
at room temperature for 30 min. The agarose beads were
washed twice with phosphate-buffered saline (PBS) contain-
ing 1% Nonidet P-40 (NP-40). The amount of protein bound
per volume of beads was equalized by adding unbound
glutathione-agarose.
The interaction of Id proteins with different bHLH pro-
teins was examined by mixing the agarose beads which were
bound to different fusion proteins with 35S-labeled in vitro-
translated proteins at 37°C for 20 min and then by washing
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four times with PBS containing 0.1% NP-40. Radiolabeled
proteins brought down by the beads were analyzed by
electrophoresis through SDS-polyacrylamide gels. The gels
were then treated with Biofluor and fluorographed.
RESULTS AND DISCUSSION
Isolation and characterization of the Id-2 gene and its cDNA
clones. In the process of isolating the Id-] gene from a mouse
genomic library, we also obtained another X phage clone,
XId2-1, which hybridized weakly to the Idl cDNA probe. By
further restriction mapping and DNA sequencing analyses,
we localized the homologous sequence to a 900-bp EcoRI
fragment (Fig. 1A). This fragment contains an open reading
frame of 222 amino acids starting at an AUG codon (see
asterisk in Fig. 1B), part of which encodes the helix-loop-
helix motif homologous to that in Idl. The reading frame
extends only a few amino acids upstream from the AUG
codon, suggesting that this AUG codon could be a transla-
tion initiation codon. To determine whether this reading
frame is transcribed, we screened a mouse thymus cDNA
library by using this EcoRI fragment as a probe and obtained
several cDNA clones. The largest clone, cId2-k, was se-
quenced. Although the cDNA encodes an AUG that could
serve as an initiation codon, the reading frame remains open
upstream from the AUG to the 5' end, suggesting that the
cDNA might not be complete at the 5' end because of a
potential premature termination of reverse transcription at a
GC-rich stretch (nucleotide 89 to 110) (Fig. 1B). Comparing
the cDNA sequence with the genomic DNA sequence, we
found that the 5' portion of the partial cDNA is identical to
the stretch of the genomic sequence from nucleotide 120 to
542 and contains the same open reading frame (Fig. 1B).
Searching the genomic sequence from nucleotide 119 up-
stream to nucleotide 38, where the possible AUG initiation
codon is located, we could not find any sequence resembling
a putative 3' splice acceptor site, suggesting that this ge-
nomic segment is part of exon 1. We thus predict that the
full-length cDNA would contain this segment and that the
reading frame of Id-2 begins at the putative initiating AUG in
the genomic sequence. However, this remains to be con-
firmed by determining the molecular weight of the natural
Id2 protein once an anti-Id2 antibody is available. By com-
paring the genomic and cDNA sequences, it is evident that
the 3' portion of the cDNA is composed of two exons, exon
2 and exon 3 (Fig. 1B), and they were mapped as shown in
Fig. 1A.
Compared with Idl, Id2 has a very similar helix-loop-helix
motif (79% homology, and most of the changes are
conservative) (Fig. 2). Both Id proteins lack a conserved
alanine residue in helix II (Fig. 2), which might influence
their dimerization properties. Id2 also does not contain the
conserved basic amino acid region thought to be responsible
for DNA binding in many bHLH proteins. It is thus very
likely that Id2 can interact with the bHLH proteins and
inhibit DNA binding just as Idl does. However, whether the
minor amino acid differences might give the two proteins
different affinities for different bHLH proteins remains to be
determined. Outside of the helix-loop-helix motif, the two
proteins are very different except for two short stretches of
weak homology (Fig. 2). It is interesting to note that these
two homology stretches are rich in serine and threonine,
which may be of regulatory importance for mechanisms like
phosphorylation. Several known phosphorylation sites such
as those for cyclic AMP-dependent kinase, protein kinase C,
and casein kinase 2, were also found in Id2.
Idl.MKVASGSAAAAAG
Id2 MAIQGCPIERPGRVHIKDAPPGSRFILNRAWCRAVSSAPCGGSLPVSP
Idl PSCSLKAGRTAGEVVL.GLSEQSVAIS AGTRLPALLDEQQVNVLLY
Id2 PTSSMKAFRSGESVRKNSLSDHSLGIS SKTPVDDPM....... SLLY
Idl DMNGCYSRLKELVPTLPONRKVSKVEILOHVIDYIRDLQLELNSESEV
:11:111:111111.:1 11:11.1:1111111111 111:. 1:1...:
Id2 NMNDCYSKLKELVPSIPQNKKVTKMEILQHVIDYILDLQIALDSHPTI
Idl GT.... TGGRGLPVRAPFLSTLNGEISLAAEAACVPADDRILCR.....
.. . I. .: I. . II. III .:III I .: I..I.:
Id2 VSLHHQRPGQNQASRTRFLTTLNTDIS LSLQASEFPSELMSNDSKVLCG
FIG. 2. Amino acid sequence comparison between Idl and Wd2.
The homologous helix-loop-helix motifs are underlined and two
serine- and threonine-enriched weak homologies are boxed. The
valine shown by an asterisk has been found to be an alanine in other
bHLH proteins.
Chromosome mapping of the Id-2 locus. The mouse chro-
mosomal location of the Id-2 locus was determined by
interspecific backcross analysis with progeny derived from
matings of (C57BL/6J x M. spretus)Fj x C57BL/6J mice.
This interspecific backcross mapping panel has been typed
for more than 675 loci that are well distributed among all the
autosomes as well as the X chromosome. C57BL/6J and M.
spretus DNAs were digested with several enzymes and
analyzed by Southern blot hybridization for informative
restriction fragment length polymorphisms by using the 1d2
cDNA probe. A 9.0-kb M. spretus-specific XbaI restriction
fragment length polymorphism was used to follow the seg-
regation of Id-2 locus in backcross mice. The mapping
results indicated that Id-2 is located in the proximal region of
mouse chromosome 12 tightly linked to Pomc-J and N-myc.
The additional loci included in this analyses are D12Nyu2
and Lambl-l.
We have compared the interspecific backcross map of
chromosome 12 with the December, 1990, chromosome 12
linkage map compiled by Davisson et al. and provided from
GBASE, a computerized data base maintained at the Jack-
son Laboratory, Bar Harbor, Maine (data not shown). This
map is based largely on genetic crosses among laboratory
mouse strains and recombinant inbred strains. These com-
parative studies indicated that the interspecific backcross
map is generally colinear with the composite map and that
Id-2 is located in a region of chromosome 12 that lacks any
known mutations with effects suggestive of an alteration in
Id-2 locus. Finally, the proximal region of mouse chromo-
some 12 in which Id-2 is located shares regions of homology
with human chromosomes 2 and 7 (Fig. 3), suggesting that
the human homolog of Id-2 may reside on one of these
chromosomes in humans.
Assignment of Id-2 to the proximal region of mouse
chromosome 12 clearly demonstrates that the locus is un-
linked to Id-], which has been assigned to mouse chromo-
some 2 (24a). But the two Id genes are probably products of
a duplication event from a common ancestor, and rearrange-
ment has occurred during evolution.
DNA binding inhibition by Idl and Id2. To test whether 1d2
could inhibit DNA binding and whether it behaves similarly
to Idl, we first chose two DNA binding bHLH proteins,
E2A.E47 and E2B.m3, as targets. E2A.E47 (30) binds
strongly to the E2 sequence in the enhancer of immunoglob-
ulin K light chain gene (KE2 sequence) (18). Benezra et al. (6)
have shown that Idl inhibited DNA binding by E47 very
efficiently. E2B.m3 is a mouse cDNA clone isolated by
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_
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_2A. E47 QMHTLKSDKAQTKLLILQQAVQVILGLEQQvRERN
E23 . -3 QLHL-KSEKPQTKLLILHQAVAVILSLEQQVRERNLNPKAACLKRREEEK
B. Idi - Id -
2 4 8 2 4 8 mock
E2A E47
:-2 3 m 3
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2p24
Drobe TCGAAAGGCG3GTGGCCCAAGCT
FIG. 4. DNA binding inhibition by Idl and Id2. (A) Amino acid
sequences of truncated E2A.E47 and E2B.m3 proteins used in the
binding assays. The two sequences are aligned to show homology.
The basic amino acid region and helix-loop-helix region are indi-
cated. (B) DNA binding by E47 and m3 in the presence of Idl or Wd2.
The molar ratio of Id to DNA binding proteins are indicated on the
top of each lane. mock, binding reactions performed by preincuba-
tion with a mock translation mix. The probe used is the KE2 site as
underlined.
7q22
FIG. 3. Position of the Id-2 locus on mouse chromosome 12. Id-2
was placed on mouse chromosome 12 by interspecific backcross
analysis. The segregation patterns of Id-2 and flanking genes in 191
backcross animals that were typed in common for Id-2 is shown at
the top of the figure. For individual pairs of loci, more than 191
animals were typed. Each column represents the chromosome
identified in the backcross progeny that was inherited from the
(C57BL/6J x M. spretus)Fj parent. The shaded boxes represent the
presence of a C57BL/6J allele, and white boxes represent the
presence of an M. spretus allele. The number of offspring inheriting
each type of chromosome is listed at the bottom of each column. A
partial chromosome 12 linkage map showing the location of Md2 in
relation to linked genes is shown at the bottom. Recombination
distances between loci in centimorgans and the standard errors are
shown to the left of the chromosome as follows: Pomc-1-2.1 +
1.0-Nmyc-0.5 .5-Id-2, 6.3 t 1.8-D12Nyu2-3.1 + 1.3-Lambl-1.
The positions of the Pomc-1, Nmyc, and Lamb]-] loci on human
chromosomes are shown to the right.
homology to E47 (Fig. 4A), but m3 is apparently encoded by
a different gene, named E2B, because its sequence dramat-
ically diverges from that of E47 outside of the bHLH region
(43). E2B.m3 also shares extended homology to the human
ITF2 protein (22), but it is not clear whether m3 is the mouse
homolog of ITF2, because the divergence between the two is
unusually high. E2B.m3 is expressed ubiquitously (data not
shown) and binds to the KE2 sequence efficiently as deter-
mined by electrophoretic mobility shift assay (Fig. 4B, lane
mock). Both the DNA binding bHLH proteins and inhibitory
Id proteins were synthesized in vitro by using rabbit reticu-
locyte lysates, and the DNA binding activity was monitored
by electrophoretic mobility shift assay. When Idl or Id2 was
preincubated with the DNA binding E47 or m3 proteins at
molar excess as indicated (Fig. 4B), the strong DNA binding
to the KE2 sequence by these proteins was completely
abolished. Apparent inhibition was also observed even when
Idl or Id2 was mixed with the binding proteins at an equal
molar ratio (data not shown), and Idl and Id2 did not show
any significant difference in their abilities to inhibit DNA
binding by either E47 or m3.
We then asked whether some bHLH protein might not be
inhibited by either Idl or Wd2. With the same protocol used
for E47 and m3, we examined truncated forms of c-myc,
TFE3, USF, and AP4 (Fig. SA). The c-myc oncogene is
involved in cell proliferation and differentiation (3), and its
DNA binding site has recently been identified as CACGTG
(7). The TFE3 protein is an apparently ubiquitous transcrip-
tion activator that binds to the E3 site (CACATG) of the
immunoglobulin heavy chain gene (5). The USF protein
(upstream stimulatory factor) is a ubiquitous cellular factor
involved in efficient transcription in vitro of the adenovirus
major late promoter, which binds to the UAE site
(CACGTG) of the adenovirus major late promoter (21). Both
TFE3 and USF can also bind strongly to the oligonucleotide
containing the binding site for c-myc, but not to the KE2
sequence (Fig. 5B). The AP4 protein is also a ubiquitous
transcription activator binding to the AP4 site (CAGCTG) of
simian virus 40 enhancer (24), but it does not bind strongly to
the KE2 sequence, the ,uE3 sequence, or the myc-binding site
(data not shown). These proteins were produced by in vitro
translation as detailed in Materials and Methods and bound
to the myc-binding sequence probe (for c-myc, TFE3, and
USF) or the AP4 site probe after preincubation with excess
amounts of Idl and Id2. DNA binding was then analyzed by
electrophoretic mobility shift assay, and no inhibition of
DNA binding by either of the Id proteins was observed for
any of these bHLH proteins (Fig. SB).
Thus, we have divided the bHLH protein family into two
subsets on the basis of their susceptibilities to Id inhibition.
The first set of bHLH proteins whose DNA binding can be
inhibited by both Id proteins includes E2A.E47 and E2B.m3.
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FIG. 5. Lack of DNA binding inhibition by Idl and Id2 on bHLH
leucine zipper proteins. (A) Schematic diagram of truncated DNA
binding proteins used in the test. The basic amino acid regions are
represented by a black bar. H, helices, shown in open boxes; LP,
loops, shown as a thin line. The leucine zippers located C terminal
to helix II are illustrated by an array of L's. The precise amino acid
positions where the proteins were truncated are as follows: c-myc,
354 to 439 (3); TFE3, 118 to 240 (5); TFE3s, 118 to 204 (5); USF, 173
to 285 (21); USFs, 173 to 284 (21); and AP4, 7 to 193 (24). (B) DNA
binding by the indicated proteins in the presence or absence of Idl
or Wd2. The molar ratios of Id to DNA binding proteins are indicated
on the top of each lane. mock, binding reactions performed by
preincubation with a mock translation mix. The specific DNA
complexes with c-myc are indicated by an arrow. The probe for
c-myc, TFE3, and USF is shown below the complexes, and the core
sequence is underlined. AP4 was bound to the AP4 site shown
below. (C) DNA binding by TFEs and UFSs in the presence or
absence of Idl or Id2 as described in panel B.
DNA binding by the E2A.E12 and MyoD proteins as ho-
modimers or as a heterodimer was also shown to be abol-
ished by Idl (6). This set of proteins falls into previously
defined class I or class II of the bHLH proteins (31), which
mutually interact to form heterodimers.
The second set ofbHLH proteins, which were not affected
by the Id proteins, belongs to the previously defined class
III. They share a common structural feature that is not
present in the proteins of the first set, namely, at least one
leucine zipper motif (28) immediately C terminal to the
second helix of the helix-loop-helix motif (Fig. 5A). The
leucine zippers of USF and AP4 have been shown to
strengthen the interaction between the two molecules in a
homodimer (21, 24). To test whether the inability of the Id
proteins to inhibit the bHLH proteins was due to strong
interactions of the bHLH homodimers facilitated by the
leucine zippers, we shortened the TFE3 and USF proteins
from their C termini to remove the leucine zippers, generat-
ing two proteins, TFE3s and USFs (Fig. 5A). DNA binding
by TFE3s and USFs in the presence of the Id proteins was
tested as described above, and still no inhibition was ob-
served (Fig. SC). These results suggest that the reason that
the Id proteins fail to inhibit the binding by this set of
proteins is not simply because of strong homodimeric inter-
action of the bHLH proteins but is most likely because of
incompatibility of the helix-loop-helix motifs in the Id pro-
teins and the bHLH proteins. The Id proteins are probably
dedicated to repress class I proteins and its associated class
II proteins, but there may be different protein molecules
serving as Id for proteins of class III proteins, or some of the
proteins may not need to be repressed by this mechanism
because they are general transcription factors active in all
cells in which they are expressed.
Interaction of Idl and Id2 with bHLH proteins. Id proteins
are thought to prevent bHLH proteins from binding to DNA
through formation of inactive heterodimers. To test this
hypothesis, we directly examined the interaction of Ids with
various bHLH proteins. We first generated GST fusion
proteins of Idl and Id2 by overexpression in E. coli and
showed that these fusion proteins were able to inhibit DNA
binding by E47 (data not shown). The proteins were then
purified by binding to glutathione-agarose beads. To detect
heterodimer formation, the beads bound with GST-Id fusion
proteins were incubated with 35S-labeled in vitro-translated
bHLH proteins used in the binding assays (Fig. 4 and 5). The
radioactive proteins which were brought down by the beads,
presumably through interacting with the Id proteins, were
analyzed by electrophoresis through SDS-polyacrylamide
gels. As shown in Fig. 6A, while GST itself did not complex
with any bHLH proteins (lanes 1), both GST-Idl and GST-
1d2 (lanes 2 and 3, respectively) can interact efficiently with
E2A.E47s and E2B.m3 and to a lesser extent with MyoD.
Both Id fusion proteins interacted very poorly with USFs,
TFE3, and AP4. Idl and 1d2 also did not form homodimers
efficiently (Fig. 6A). Using a similar approach as described
above, we also analyzed the interaction of 35S-labeled in
vitro-translated Idl and 1d2 with GST-E12 and GST-E47
fusion proteins and found that both E12 and E47 can form
complexes with the two Id proteins (Fig. 6B, lanes c and d).
Because these experiments were performed with excess
GST fusion proteins to allow complete heterodimerization,
the efficiency of heterodimer formation can be estimated
qualitatively by comparing the amount of protein precip-
itated (lanes 1, 2, and 3 of Fig. 6A or lanes b, c, and d of Fig.
6B) with the input amount (lane 4 of Fig. 6A and lane a of
Fig. 6B show 50% of the input).
These results provide a molecular basis for inhibition of
DNA binding by Id proteins through formation of het-
erodimers. We found that the bHLH proteins, whose bind-
ing activities could be inhibited, formed heterodimers with
Id proteins, but those whose activities were not inhibited did
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FIG. 6. Interaction of Idl and Id2 with bHLH proteins. (A)
bHLH proteins mixed with Idl and Id2-GST fusion proteins.
35S-labeled in vitro-translated bHLH proteins, as indicated on the
top of each panel, were incubated with glutathione-agarose beads
bound to equivalent amounts ofGST (lane 1), GST-Idl (lane 2), and
GST-Id2 (lane 3). Lane 4, total translation extract of each indicated
protein at an amount approximately 50%o of what was used for lanes
1 to 3. Translated E47S and MyoD proteins are pointed out by
arrows. (B) Idl and Id2 proteins mixed with GST-E12 and GST-E47
fusion proteins. 35S-labeled in vitro-translated Idl and Id2, as
indicated on the top of each panel, were incubated with glutathione-
agarose beads bound to equivalent amounts of GST (lane b),
GST-E12 (lane c), and GST-E47 (lane d). Lane a contained total
translation extract of Idl or Id2 at an amount approximately 50% of
what was used for lanes b to d.
not interact with the Id proteins. These results also
strengthen our conclusion that the primary targets of the Id
proteins Idl and Id2 were products of the E2A and E2B
genes or the class I bHLH proteins. The class II bHLH
proteins may also complex with Id proteins, but the interac-
tion is less efficient, as in the case of MyoD which both we
and Benezra et al. (6) found to form less complex with Idl or
Id2. We also found that tal, another class II bHLH protein
(23), did not interact with Idl and interacted very weakly if
FIG. 7. Northern blot analysis of Idl and Wd2. Equal amounts of
total RNA were loaded on the gel as described in Materials and
Methods. Idl mRNA was estimated to be 1.2 kb (6), and Id2 mRNA
appears to be 1.6 kb.
at all with Id2 (data not shown). Considering that several
control mechanisms, such as tissue-specific gene expression
(29) and the dependence of their DNA binding activities on
formation of heterodimers with the class I proteins (23, 42),
already exist for the class II proteins, it may be less
important for class II proteins to have the Id proteins as
additional regulators. In contrast, the constitutively ex-
pressed class I proteins need to be inhibited by the Id
proteins at a defined developmental stage or cell type.
Moreover, sequestering the class I proteins could indirectly
inhibit class II proteins, whose function depends on the class
I proteins. The fact that the Id proteins exist mostly as
monomers should also make them more effective inhibitors
for the class I proteins.
Expression of the Id-] and Id-2 genes. The Id proteins are
clearly efficient negative regulators for a specific set of
bHLH proteins. One might then expect that the regulation of
expression of the Id-] and Id-2 genes would correlate with
their functional roles. Because the Id proteins inhibit the
function of bHLH proteins involved in cellular differentia-
tion, we examined the levels of Idl and Id2 mRNAs in
several cell types at different stages of differentiation by
Northern blot analysis (Fig. 7). In general, Idl and Id2 were
expressed at different levels in different cell types, but their
expression was down-regulated by cell differentiation in all
of the cell types examined. For B lymphocytes, we analyzed
RNAs from cell lines whose developmental stages have been
defined on the basis of the patterns of transcription and
rearrangement of the immunoglobulin genes and found that
the level of Id-] is higher than that of Id-2 and the expression
of both genes was decreased as differentiation proceeded
from pro-B cells (LyD9), to pre-B cells (HAFTL and PD31),
to mature B cells (WEHI-231). Similar results were also
observed when the levels of RNA were measured with PCR
assays (38). In MEL cells, Idl was hardly detected while Id2
was very abundant, but the expression of Id2 was dramati-
cally shut off after the cells were induced to differentiate with
1.5% dimethyl sulfoxide for 48 h. (Benezra et al. [6] had
previously clearly detected Idl in MEL cells; the difference
from our result might be due to variations of sources ofMEL
cells or simply due to the different sensitivities of the
analyses.) Induction of mouse F9 embryonal carcinoma cells
also reduced the expression of both Id-] and Id-2 genes. The
expression of Id-i was also shut off in F3 aza-myoblasts
upon differentiation (6).
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These data enlarge upon the role of Id protein as a
negative regulator first postulated by Benezra et al. (6).
First, we have shown that there are two Id proteins, encoded
by unlinked distinct genes, that vary in their relative con-
centrations in different cell lineages. Second, we have found
that both Idl and Id2 interact to a different extent with a
distinct subset of bHLH proteins, those previously defined
as class I and class 11 (31). The other set of bHLH proteins,
mostly the class III proteins (31), are resistant to interaction
with Id, and some, at least, appear to exist mainly as
homodimers. Third, we have demonstrated that in quite a
number of differentiating systems, Idl and/or Id2 are at
relatively high levels in immature cells and that their con-
centration falls to undetectable levels as differentiation pro-
ceeds.
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ADDENDUM
Since the submission of the manuscript, Christy et a1.
reported the cloning of an Id-like protein named HLH462
(Proc. Natl. Acad. Sci. USA 88:1815-1819, 1991). This
protein shares amino acid sequence homology with both Idl
and Id2 in the helix-loop-helix region with some divergence
in the loop. HLH462 also contains one of the serine- and
threonine-rich homology regions discussed in the text. Be-
cause Idl and Id2 are more closely related, HLH462 should
probably be considered Wd3.
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